(Axios) – The Food and Drug Administration’s top vaccine regulator will leave the agency at the end of April, a Department of Health and Human Services spokesperson confirmed to Axios.

Why it matters: Vinay Prasad, director of FDA’s Center for Biologics Evaluation and Research, has presided over controversial decisions including declining to review Moderna’s new mRNA flu vaccine approval application — a decision that was later reversed. (Read More)